General
Preferred name
ETHIONAMIDE
Synonyms
3-Ethyl-thio-isonicotamide ()
2-ethylthioisonicotinamide ()
Bayer 5312 ()
Ethinamide ()
PMID28454500-Compound-96 ()
Trecator ()
BAYER 5312 ()
Ethionamidum ()
1314 TH ()
1314-TH ()
Trecator-Sc ()
Nizotin ()
NSC-255115 ()
Ethionamide-d3 ()
P&D ID
PD002335
CAS
536-33-4
5261-38-1
2748267-66-3
Tags
prodrug
natural product
drug
available
Approved by
FDA
First approval
1965
Drug Status
approved
Drug indication
Tuberculosis
Antibacterial (tuberculostatic)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
0
Organisms
2
Compound Sets
20
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
44
Properties
(calculated by RDKit )
Molecular Weight
166.06
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
1.28
TPSA
38.91
Fraction CSP3
0.25
Chiral centers
0.0
Largest ring
6.0
QED
0.67
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
oxidation-reduction
Anti-infection
Target
CAT
NAPDH
antibiotic
Bacterial
Antibiotics
Indication
tuberculosis
MOA
mycolic synthesis inhibitor
Therapeutic Class
Antituberculosis Agents
Source data